Background Heart failure presents a growing clinical and economic burden in the USA.
Robust cost data on the burden of illness are critical to inform economic evaluations of new …

The HeartMate 3 left ventricular assist device (LVAD) is now the only centrifugal pump
intended for durable support being actively manufactured and implanted for adults in the …

Background: Ischemic and hemorrhagic cerebrovascular accidents remain common among
patients with centrifugal-flow left ventricular assist devices, despite improvements in survival …

Objectives: The purpose of this study was to examine outcomes after left ventricular assist
device (LVAD) implantation in older adults (> 75 years of age). Background: An aging heart …

Left ventricular assist device (LVAD) implantation is an established treatment for patients
with advanced heart failure refractory to medical therapy. However, the incidence of …

As the population ages and the prevalence of heart failure increases, cardiologists and
geriatricians can expect to see more elderly patients with heart failure in their everyday …

Background Left ventricular assist devices (LVADs) generate electromagnetic interference
that causes high‐frequency noise artifacts on 12‐lead ECGs. We describe the causes of this …

Background We aimed to evaluate the acute kidney injury (AKI) incidence and its associated
risk of mortality in patients with implantable left ventricular assist devices (LVAD). Methods A …

Abstract Purpose of Review Concomitant valve disease is common in patients undergoing
continuous-flow left ventricular assist device (CF-LVAD) implantation. In this review, we …

Remote monitoring is becoming increasingly important for management of chronic heart
failure patients. Recently, hemodynamic monitoring by measuring intracardiac filling …